Watch Ticker

Larimar Therapeutics, Inc. Common Stock

Go to Larimar Therapeutics, Inc. Common Stock Website

$3.71

0.40 (11.93%)

Live

Previous Close

$3.31

Day Range

$3.66 - $4.2252

Previous Day Range

$3.175 - $3.55

Market Cap

$220.3 million USD

Day Vol.

6.6 million

Previous Day Vol.

1.5 million

Currency

USD

Primary Exchange

Nasdaq

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Globe Newswire - Larimar Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

Larimar Therapeutics completed a public offering of 21,562,500 common stock shares at $3.20 per share, raising $69.0 million to support drug development and corporate operations.

Related tickers: LRMR.

Read Full Article

Larimar Therapeutics, Inc. - Larimar Therapeutics Announces Pricing of Underwritten Public Offering

Larimar Therapeutics plans to raise $60 million through a public offering of 18,750,000 common stock shares at $3.20 per share, with proceeds intended to support drug development and corporate operations.

Related tickers: LRMR.

Read Full Article

Trending Tickers

Please sign in to view